Tentt

Astria Therapeutics Acquired by BioCryst Pharmaceuticals — Healthcare M&A

Closed
HealthcareNorth CarolinaMerger

Deal Summary

BioCryst Pharmaceuticals completed its acquisition of Astria Therapeutics for about $700M to expand hereditary angioedema therapies.

Key Details

Transaction
BioCryst Pharmaceuticals acquires Astria Therapeutics
Deal Size
Over $100M
Reported Value
$700 million

Source

Read full article on news.google.com

via GN - site:globenewswire.com · January 23, 2026

Related Deals